| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/06/2013 | US20130142810 Use of the combination of semaphorin-4d inhibitory molecules and vegf inhibitory molecules to inhibit angiogenesis |
| 06/06/2013 | US20130142809 METHODS OF TREATMENT USING AN IFN gamma INHIBITOR |
| 06/06/2013 | US20130142808 Antibody recognizing human leukemia inhibitory factor (lif) and use of anti-lif antibodies in the treatment of diseases associated with unwanted cell proliferation |
| 06/06/2013 | US20130142807 Compositions and methods for inhibition of the jak pathway |
| 06/06/2013 | US20130142805 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 06/06/2013 | US20130142803 Haemophilus Influenzae Type IV PILI |
| 06/06/2013 | US20130142801 Antibody to human zcyto-10 polypeptide |
| 06/06/2013 | US20130142800 Mycobacterial Antigen Composition |
| 06/06/2013 | US20130142796 Treatment for angiogenic disorders |
| 06/06/2013 | US20130142794 Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS |
| 06/06/2013 | US20130142790 Method of Treating Cancer Using a cMET and AXL Inhibitor and an ErbB Inhibitor |
| 06/06/2013 | US20130142789 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies |
| 06/06/2013 | US20130142787 Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis |
| 06/06/2013 | US20130142785 HER2 Targeting Agent Treatment in Non-HER2-Amplified Cancers having HER2 Expressing Cancer Stem Cells |
| 06/06/2013 | US20130142784 Method of treating tumor resistant to herceptin or paclitaxel using foxm1 inhibitors and detecting same |
| 06/06/2013 | US20130142778 Compositions for inhibiting gene expression and uses thereof |
| 06/06/2013 | US20130142755 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject |
| 06/06/2013 | CA2857666A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | CA2857647A1 Methods and compositions for increasing arylsulfatase a activity in the cns |
| 06/06/2013 | CA2857423A1 Novel targets of acinetobacter baumannii |
| 06/06/2013 | CA2857159A1 Drug containing carrier into cell for forming immune complex |
| 06/06/2013 | CA2857087A1 Influenza virus vaccines and uses thereof |
| 06/06/2013 | CA2857025A1 Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof |
| 06/06/2013 | CA2856895A1 Anti-pd-l1 antibodies and uses thereof |
| 06/06/2013 | CA2856804A1 Polypeptide adjuvant |
| 06/06/2013 | CA2855566A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors |
| 06/06/2013 | CA2850293A1 Hpv chimaeric particle |
| 06/06/2013 | CA2762446A1 Use of the combination of semaphorin-4d inhibitory molecules and vegf inhibitory molecules to inhibit angiogenesis |
| 06/05/2013 | EP2599866A1 Novel nucleic acid having adjuvant activity and use thereof |
| 06/05/2013 | EP2599860A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same |
| 06/05/2013 | EP2599793A1 Anti-phospho-akt antibodies |
| 06/05/2013 | EP2599792A1 Antibody directed against PcrV |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2599496A1 Novel targets of Acinetobacter baumannii |
| 06/05/2013 | EP2598631A1 Recombinant bacterium and uses thereof |
| 06/05/2013 | EP2598533A2 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| 06/05/2013 | EP2598521A1 Recombinant neisseria meningitidis por a porin proteins |
| 06/05/2013 | EP2598173A2 Vaccines against pregnancy-associated malaria |
| 06/05/2013 | EP2598168A2 Combination therapy for treating cancer comprising an igf-1r inhibitor and an akt inhibitor |
| 06/05/2013 | EP2598167A1 Stabilized aqueous antibody compositions |
| 06/05/2013 | EP2598166A1 Mhc-less cells |
| 06/05/2013 | EP2598165A1 Immunogenic anti-inflammatory compositions |
| 06/05/2013 | EP2598164A2 Peripheral blood sparc antibodies and uses thereof |
| 06/05/2013 | EP2598163A1 Recombinant trypanosoma theileri parasite |
| 06/05/2013 | EP2598126A2 Methods of treating pain |
| 06/05/2013 | EP2598120A2 Compositions and methods for inducing immune tolerance |
| 06/05/2013 | CN1871025B Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS) |
| 06/05/2013 | CN103140501A Cancer therapy using cldn6 target-directed antibodies in vivo |
| 06/05/2013 | CN103140500A Anti-addl monoclonal antibody and uses thereof |
| 06/05/2013 | CN103140240A Antibodies to matrix metalloproteinase 9 |
| 06/05/2013 | CN103140239A Method of storing a vaccine containing an aluminum adjuvant |
| 06/05/2013 | CN103140238A Immunogenic anti-inflammatory compositions |
| 06/05/2013 | CN103140237A Factor ix polypeptides and methods of use thereof |
| 06/05/2013 | CN103140233A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 06/05/2013 | CN103140229A Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
| 06/05/2013 | CN103131719A Taenia multiceps enolase TmENO recombinant protein with immunizing protection |
| 06/05/2013 | CN103130896A Monoclonal antibody for resisting cell surface ectopic expression, and preparation method and application thereof |
| 06/05/2013 | CN103130895A Specific binding members against synaptophysin |
| 06/05/2013 | CN103130877A Human immunodeficiency virus type I Tat protein mutant 1-37-site sequence and application thereof |
| 06/05/2013 | CN103130873A Antituberculous CTL (Cytotoxic T Lymphocyte) epitope peptide with drug-resistant related efflux protein source for tuberculosis and application of epitope peptide |
| 06/05/2013 | CN103127503A Application of antagonizing and/or blocking IL-6/IL-6R/gp130 signaling pathway in treatment of anti-hepatoma |
| 06/05/2013 | CN103127502A Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 06/05/2013 | CN103127501A Artificial synthetic adjuvant for avian influenza intranasal immunization |
| 06/05/2013 | CN103127500A Application of porphyrin pigment serving as immunologic adjuvant and vaccine |
| 06/05/2013 | CN103127499A Conjugate vaccine |
| 06/05/2013 | CN103127498A Recombination antigen composition, vaccine and carrier and method for preparing antigen composition |
| 06/05/2013 | CN103127497A Bigeminy inactivated vaccine of porcine circovirus type 2 and swine mycoplasma hyopneumoniae and preparation method of bigeminy inactivated vaccine |
| 06/05/2013 | CN103127496A III type turkey herpes virus freeze-drying vaccine |
| 06/05/2013 | CN103127495A Goat pasteurella multocida inactivated vaccine, goat filiform mycoplasma pneumonia inactivated vaccine and preparation thereof |
| 06/05/2013 | CN103126999A Thymalfasin chitosan / beta-cyclodextrin composite microsphere drug delivery system and preparation method |
| 06/05/2013 | CN103126996A Methods and compositions for intranasal delivery |
| 06/05/2013 | CN102766604B Swine influenza virus strain and application thereof |
| 06/05/2013 | CN102671209B Heat-resistant freeze-drying protective agent for newcastle disease live vaccines and preparation method |
| 06/05/2013 | CN102671207B Newcastle disease and avian infectious bronchitis bigeminal live vaccine heat-resisting freeze-drying protective agent and preparation method |
| 06/05/2013 | CN102641504B Heat-resistant freeze-drying protecting agent for vaccine and preparing method |
| 06/05/2013 | CN102608333B Tuberculosis diagnostic composition and application thereof |
| 06/05/2013 | CN102477096B Human creatine kinase single-chain antibody with molecular chaperone function |
| 06/05/2013 | CN102397559B Broad spectrum type influenza vaccine and preparation method thereof |
| 06/05/2013 | CN102392031B Schistosoma japonicum thioredoxin glutathione reductase gene and DNA (deoxyribonucleic acid) vaccine thereof |
| 06/05/2013 | CN102372773B Human bladder cancer tumor marker, antibody thereof and application thereof |
| 06/05/2013 | CN102302775B Combined inactivated vaccine of Newcastle disease and H9 subtype avian influenza and preparation method thereof |
| 06/05/2013 | CN102294025B Compound of prostate stem cell antigen polypeptide and nucleic acid and preparation method and application thereof |
| 06/05/2013 | CN102286408B Bacillus amyloliquefaciens WH3, and preparation method and application thereof |
| 06/05/2013 | CN102276725B Cryptosporidium CTL and Th mixed multi-epitope gene and fusion protein and application |
| 06/05/2013 | CN102258780B Lyophilized mite allergen vaccine and preparation method thereof |
| 06/05/2013 | CN102247595B Application of polyinosinic-polycytidylic acid (poly I:C) combined dimo-thylidioctyl ammonium bromide (DDA) mixed adjuvant in preparation of tuberculosis subunit vaccines |
| 06/05/2013 | CN102212113B Tuberculosis medicament resistance related tuberculosis-resisting cytotoxic T lymphocyte (CTL) epitope peptide derived from refflux protein and application thereof |
| 06/05/2013 | CN102212112B MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof |
| 06/05/2013 | CN102206257B Edwardsiella tarda immunogenic protective antigen, and related expression vector, vaccine and application |
| 06/05/2013 | CN102180950B Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 06/05/2013 | CN102166355B Quadruple inactivated vaccine for preventing chicken diseases |
| 06/05/2013 | CN102038951B Nucleic acid vaccine adjuvant designed based on MCP-1 and construction method thereof |
| 06/05/2013 | CN102028946B Taxus mairei immunological adjuvant and influenza vaccine containing same |
| 06/05/2013 | CN101954077B Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 06/05/2013 | CN101921733B Preparation method and application of Qbeta-2aa phage virus-like particle protein |
| 06/05/2013 | CN101921725B Converter for inhibiting hen somatostatin action through oral immunization and application thereof |
| 06/05/2013 | CN101914564B Fusion of multiple enterotoxin genes of escherichia coli and application thereof |
| 06/05/2013 | CN101863984B Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane |
| 06/05/2013 | CN101863964B Helicobacter pylori urease B antigen epitope polypeptide and application thereof |
| 06/05/2013 | CN101848732B Methods of reducing eosinophil levels |